Catalyst Wire Dossier Catalyst Wire Dossier

Asasantin

dipyridamole · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Asasantin, covering 2014-10-21 to 2014-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects [Phase 1]

See pricing